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ABSTRACT 
Vibrio cholerae, a Gram-negative bacterium, is responsible for the acute intestinal infection 
known as cholera. This illness is due in part to V. cholerae’s ability to sense and adapt to 
changing environments as it is ingested into the human body from brackish environments. It was 
shown in recent studies that this bacteria has the ability to uptake exogenous fatty acids, resulting 
in changes to V. cholerae persistence and pathogenicity [5]. The aim of this research is to 
determine the extent to which these additional exogenous UFAs influence the persistence and 
pathogenicity of V. cholerae throughout its transitional period from brackish environments to 
human host conditions. Our hypothesis is that environmental conditions (e.g., temperature, pH, 
salinity) direct fatty acid-induced changes in V. cholerae’s capacity to spread disease by 
triggering changes in the bacterium’s virulence factors such as: biofilm formation, antibiotic 
resistance, and cholera toxin production. Initial work focused on identifying the environmental 
conditions that trigger fatty acid-induced changes in V. cholerae persistence and pathogenicity 
using a design of experiments approach. The final work of this project focused on literary 
analysis of effect of the exogenous fatty acids on V. cholerae’s genetic regulatory pathways.
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Chapter 1. Scope of Work 
1.1 Initial Focus 
As originally proposed, this work was to experimentally determine key environmental 
variables that influence Vibrio cholerae persistence and pathogenicity. Previous studies have 
shown that V. cholerae has the ability to uptake exogenous unsaturated fatty acids (UFAs) into 
its cellular membranes. It is theorized that these fatty acids then act to repress or enhance gene 
expression within the bacteria [1]. By using two UFAs found in the human body and two 
associated with marine environments, environmental influence can be measured quantitatively 
by observing both persistent and pathogenetic traits. Persistent traits are measured through 
antibiotic resistance while pathogenicity is measured through toxin production and biofilm 
formation. Our hypothesis is that environmental conditions (e.g., temperature, pH, salinity) direct 
fatty acid-induced changes in V. cholerae’s ability to survive and spread disease. This was to be 
done using a design of experiments approach, seen below in figure 1.  
 
Figure 1. Experimental Approach for Variable Isolation 
Initially measuring antibiotic resistance and biofilm formation in the bacterium’s two 
environments, human host and brackish waters, allows for further isolation of each 
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environmental variable. By using these two environmental conditions as base cases for 
comparison, one variable such as pH can be varied while holding all others static, allowing for 
determination of key environmental triggers. These extremes would be similarly used for 
comparison to a transition from marine to human host, mimicking the ingestion of the bacterium.  
1.2 Deviations in Experimental Data and Protocols 
In order to collect this data, protocols were researched and established, many of which were 
customized from procedures used in different labs. This was necessary to adapt each assay to our 
bacterium, media, fatty acid utilization, and environmental conditions. However, upon changing 
these methods, variations in results were apparent. Due to the variation in protocols from 
previous studies and the addition of fatty acids, there was no mean for data comparison with 
published studies. After isolating and resolving several suspected causes of the inconsistencies 
with no change in results, the work began to include and eventually solely focus on perfecting 
protocols and further exploration of V. cholerae’s regulatory networks through literature 
research.  
1.3 Final Focus 
Upon awarding of a CEACSE (Center of Excellence in Applied Computational Science and 
Engineering) award, data collection was to be carried out in a microbiology lab, as specified 
within the grant, for access to more materials. Due to this, a hold was placed on current variable 
laboratory experiments until this change of location took place. Similarly, an increased focus on 
grant writing required literature research on experimental niches. The CAREER Award, granted 
by the National Science Foundation, is given to junior faculty integrating education and research. 
In order to apply for this, it was essential to find an unexplored niche regarding V. cholerae’s 
regulatory cascade. While studies have been published regarding individual genes within V. 
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cholerae, there is little known about the overall hierarchy of the operons controlling persistence 
and pathogenicity. The final focus of this thesis is the development of protocols and literature 
research regarding the understanding of V. cholerae’s regulatory pathways.  
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Chapter 2. Introduction 
2.1 Infectious Diseases and their Transmission 
Infectious diseases kill approximately 17 million a year worldwide, translating to as many as 
47 thousand individuals a day or 19 hundred an hour. Emerging infections are defined as 
infections that have either not yet occurred in humans, have only infected a small amount of 
people, or have been only recently recognized. Examples of these include HIV/Aids, Lyme 
disease, and Ebola. Reemerging infections are diseases that were at once a significant health 
issue for a large population, disappeared, and have since begun infecting populations again. This 
type of infection includes tuberculosis, rabies, and malaria [2, 3]. According to the World Health 
Organization 2007 report, these types of infections are occurring at an increasingly large rate. 
Since 1970, approximately 40 new diseases have been identified and, in the last 5 years, there 
were 1,100 identified outbreaks across the world [4].   
 Virulence, the severity of a disease, can be further enhanced by the mode of transmission. 
The World Health Organization estimates that food- and waterborne pathogens kill 
approximately 2 million people a year. Waterborne illnesses can occur via ingestion of water 
contaminated with microorganisms, often introduced by feces. Outbreaks predominately occur in 
third world countries due to lower sanitation levels; public health measures detect and filter 
bacterial pathogens found in water supplies and the lack thereof allows them to progress 
unregulated. To date, roughly 1.1 billion people across the world live without safe water and 2.6 
billion live without proper sanitation [4]. Additional risk factors for waterborne bacterial 
pathogens include droughts, climate change and high temperatures, and increased populations, 
all of which are found frequently in developing countries [3]. Droughts increase the bacterial 
concentration in the depleted water levels, while climate change can increase precipitation events 
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causing the flooding of water and sewage treatment facilities, and larger populations allow for 
increased transmission.  
Higher oceanic temperatures further provide preferable growth conditions for bacteria [5]. 
According to the EPA, sea temperature is increasing at a rate of 0.13ºF per decade [6]. Not only 
do warmer temperatures promote bacterial growth but they also promote algae growth and 
copepod survival. Studies show these not only support the bacterium but also provide a degree of 
resilience to pH and temperature variability [7]. With increased algae and copepod populations, 
bacteria populations grow and become more apt to survive varying environmental conditions.  
V. cholerae, the waterborne pathogen responsible for the acute intestinal illness known as 
cholera, is heavily influenced by these environmental triggers. Likewise, V. cholerae associates 
with extant organisms such as algae, copepod, and fish populations as reservoirs for survival 
during dormancy, using carbon and nitrogen from the chitin present [8, 9]. As populations grow 
and migrate to cities, human interaction increases, along with the likelihood of spreading 
infectious diseases. Globalization, the interaction of governments and people around the world, 
also poses an increased likelihood of disease development. As people travel and countries trade 
goods, the possibility of infected individuals or contaminated goods transmitting disease 
becomes more distinct. In 1991, Latin America had its first cholera epidemic in a century. What 
began with a single case in January, thought to have been carried via contaminated seafood from 
Peru, spread rapidly and by mid-April a hospital in Lima was receiving approximately 162 
cholera cases a day. By the end of the year, there were 400,000 reported cases and 4,000 deaths 
in Latin America. By 1995, there were 1 million cases reported and 10,000 dead in these regions 
[4, 10]. This efficient model of infectious disease dissemination can be seen in many other 
bacterial pathogens. 
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2.2 Vibrio cholerae  
Vibrio cholerae is a comma shaped, Gram-negative bacterium with pili and a single 
flagellum [11]. Figure 2 below shows a transmission electron microscopy (TEM) image of V. 
cholerae at a magnification of 6,000 at 35mm in size. 
 
     Figure 2. TEM image of V. cholerae [12] 
 
Current studies report the bacterium results in as many as 143,000 deaths a year, with over 4 
million cases reported a year [13]. Like most waterborne pathogens, it is found chiefly in 
developing nations where bathing and drinking water is unpurified. This water has often been 
contaminated with the feces of an infected individual, where the bacterium can grow and 
reproduce.  
Originally living either attached to copepod, algae, and fish populations or as free-living 
cells, V. cholerae remains dormant and non-virulent. Upon ingestion, the bacterium surviving the 
acidity of the stomach must adhere to and colonize the epithelial cells of the duodenum, the first 
portion of small intestine immediately after the stomach. In order to do this, the flagellum allows 
V. cholerae to penetrate the outer mucus layer of the duodenum so that the pili can further aid in 
colonization of the ileum, a later portion of the small intestine. Upon colonization via biofilm 
formation, the bacterium produces cholera toxin (CTX), the protein complex responsible for the 
characteristic diarrhea of the disease. Upon return to the environment, V. cholerae exists again as 
free-living cells in reservoirs as previously mentioned [14].  
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Over time, V. cholerae has evolved and adapted to survive two conditions: an aquatic 
environment and the human host. In the ocean, the bacteria may exist in a free-standing dormant 
state or it may inhabit various marine organisms. Here it must resist phagocytosis, low 
temperatures, higher salt concentrations, and starvation. In the human host, the bacteria must 
contend with stomach acidity, digestive secretions (e.g. bile), and immune system defenses. V. 
cholerae commonly remains in a dormant state in aquatic environments, but upon ingestion, will 
colonize the small intestine, forming biofilms and secreting an enterotoxin. The host then suffers 
from severe, watery diarrhea and, if left untreated, may die [15, 16] Most serotypes of V. 
cholerae are differentiated based on the presence or absence of the O antigen on the 
lipopolysaccharide of the outer membrane. The two major O serogroups, O1 and O139, produce 
cholera toxin and are the most common pathogenic strains [17]. These strains have virulence 
factors attributing to the pathogenicity and persistence of the bacterium. 
2.3 Pathogenicity and Persistence 
Pathogenicity is a bacteria’s ability to spread disease. This is key to bacterial survival 
because it grants the opportunity for a pathogen to grow, multiply, and be released back to a 
reservoir for new infections. This trait can be measured via virulence factors. V. cholerae, a 
primary pathogen, has strains with both little to no virulence factors and strains with several that 
have been selected for over time. Pathogenic strains O1 and O139 use mechanisms like toxin 
production, a toxin-coregulated pilus, and biofilm formation to efficiently colonize and cause 
disease within a host. 
Cholera toxin, in short, causes the epithelial cells to lyse, secreting electrolytes and water into 
the intestinal lumen. As CTX is produced, it binds to the external receptors of enterocytes to 
trigger endocytosis. Once inside the cell, it locks into place, resulting in the overproduction 
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cAMP. This activates the chloride channel proteins, causing an efflux of chloride ions from 
enterocytes while disabling the intestine from reabsorbing them. This buildup of ions results in 
the watery diarrhea characteristic of the disease [18]. 
 Pili are typically used for mobility, adherence, and biofilm formation. The toxin-coregulated 
pilus (TCP) is not a direct cause of cholera symptoms, but instead is necessary for colonization 
of the small intestine.  This is done by holding the bacterial cells together to form microcolonies. 
It is also theorized that the TCP aids in adhesion to host epithelial cells.  
A biofilm is an aggregate of microorganisms with the ability to attach to surfaces or other 
microorganisms. Biofilm formation allows V. cholerae to adhere to the epithelial lining of the 
small intestine, reproduce, and eventually cause disease. Without this extracellular matrix, the 
bacterium would simply pass through the digestive tract of an infected individual, unable to 
cause disease. However, V. cholerae produces robust biofilms, allowing it to be studied as a 
mode of pathogenesis. Furthermore, V. cholerae also produces biofilms in the aquatic 
environment as a means of persistence. 
Bacterial persistence is a phenotypic characteristic in which bacteria are able to survive 
environmental stressors. Bacteria that exhibit these traits are often the more fit of the population, 
using slower growth to acquire genetic mutations that are passed down to future offspring. In 
marine environments, this can be characterized by the viable but nonculturable (VBNC) state. 
Within this state, bacteria can become dormant while remaining metabolically active. These 
bacteria are also smaller and cannot be grown on growth media. This allows V. cholerae to 
withstand stress-inducing situations like high salinity or nutrient deprivation, common in marine 
conditions [19, 20].  
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In the host, this can be characterized by measuring antibiotic resistance in a culture. As 
antibiotics are developed through modern medicine, bacteria have begun to evolve in response. 
Any bacteria that survive treatment with antibiotics are then able to pass on this resistance to 
offspring. Through this evolution, bacteria become more fit. By exposing V. cholerae to 
antibiotics and measuring growth over time, the persistence of the bacteria can be quantified. 
2.4. Environmental Cues 
As previously discussed, V. cholerae survives two environmental conditions: brackish waters 
and the human host. In the marine environment, the bacteria withstand a temperature of 30ºC, a 
pH of 8.0, and a salinity of 600mM. In the human body, the bacteria are then able to survive a 
temperature of 37ºC, a pH of 7.2, and a salinity of 150mM. Recent studies have shown that V. 
cholerae actually uses these environmental stimuli to adapt to its changing surroundings, along 
with sodium bicarbonate and bile. Environmental conditions are responsible for bacteria entering 
the VBNC state. Low nutrient levels, higher osmolarities, and lower temperatures can all induce 
this dormancy. According to previous research, bacteria in this state can be resuscitated back to a 
culturable state after being cocultured with eukaryotic cells, meaning upon ingestion, these 
dormant bacteria can become active again [19, 20]. 
It has been shown that free-living V. cholerae are highly sensitive to low pH, while V. 
cholerae encompassed in biofilm are more acid resistant, meaning this resistance to acid could 
promote survival during passage through the stomach and small intestine [21]. Similarly, bile, an 
acidic fluid present in the small intestine, enhances motility but represses other virulence factors 
like CTX and biofilm production. When first ingested and bile is present, CTX production and 
biofilm formation is potentially repressed. At this point, there is no need for toxin secretion as it 
would be a waste of energy and would have no effect on the host. At this same time, motility is 
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increased. At these early stages of infection, motility is crucial for initial penetration into the 
epithelial cells and biofilm formation would inhibit this from occurring. However, once within 
the epithelial cells, V. cholerae must begin to form microcolonies through the use of biofilm and 
secrete cholera toxin, both of which are expressed in the absence of bile [22].   
Bile acts as a natural effector in V. cholerae due to the unsaturated fatty acids present within, 
namely linoleic and arachidonic acids. Previous studies have shown that this bacterium has the 
ability to uptake exogenous fatty acids through its cell envelope, structurally altering its 
phospholipids [22, 23]. In addition to membrane remodeling, these long-chain UFAs can be used 
for energy production, via b-oxidation, or possibly as signaling molecules controlling the 
virulence cascade. If used for membrane remodeling, the bacteria become more or less fit for 
stress resistance. This can be quantified via antibiotic resistance. If used as a signaling molecule, 
this triggers changes in the aforementioned virulence factors, namely motility, biofilm formation, 
and toxin production.  
2.5 Unsaturated Fatty Acids 
According to emerging studies, several external factors assist V. cholerae in persistence and 
pathogenicity throughout its life cycle. V. cholerae has the ability to uptake exogenous 
unsaturated fatty acids into its cellular membranes to a larger degree than most bacteria. These 
fatty acids then repress or enhance virulence factors like biofilm formation, motility, and 
antibiotic resistance [24]. At early stages of infection, many virulence genes are repressed. At 
this stage, the bacteria have not yet colonized, and virulence genes are not yet needed. At this 
same stage, however, motility is increased, allowing the bacteria to more efficiently penetrate 
into the epithelial cells [22]. Upon further examination, the presence of specific unsaturated fatty 
acids (UFAs) was shown to play a role in these changes. The UFAs were identified as 
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arachidonic acid, linoleic acid, and oleic acid. It was shown that, while each inhibited CT 
production, linoleic acid did so by over 30-fold [23].  
While the effect of specific fatty acids to virulence factor alterations has been previously 
studied, these effects throughout the marine to host transition have not. Therefore, this project 
aims to identify how exogenous UFAs influence the persistence and pathogenicity of V. cholerae 
in real-time during the transition from a marine environment to the human host. The UFAs 
studied in this project were: linoleic (18:2) and arachidonic (20:4) acids (host), and 
eicosapentaenoic (20:5) and docosahexaenoic (22:6) acids (marine). Linoleic and arachidonic 
acids were chosen to represent the human host as they are found in bile and intestinal mucosa. 
Eicosapentaenoic and docosahexaenoic acids were chosen to represent brackish waters as they 
are omega-3 fatty acids found in fish oils.
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Chapter 3. Protocols and Assays1 
3.1 Media 
Growth medium is designed to support cell growth and there are different types for each type 
of cell, assay, etc. Three types of media were used throughout this project: Lysogeny Broth (LB), 
M9 minimal media, and HEPES. LB is commonly used for bacterial growth and is nutritionally 
rich. Rich media is preferred when trying to overproduce a characteristic; the goal is a high 
product yield without concern as to what the bacteria is being fed. M9 media contains only the 
bare basics necessary for cell growth, nothing more. Due to this, it is typically supplemented 
with nutrients. Minimal media is typically used in experimental analyses. Without excess 
nutrients, any observed data trends can be accounted to the independent variable tested. Finally, 
HEPES is a pH buffered media. When culturing bacteria, pH fluctuates due to carbon dioxide 
and other byproducts released during cellular respiration. As this project aims to rule out various 
environmental factors such as pH as causative agents, it’s essential to keep this constant while 
testing other variables.  
In every media, additives are used as supplemental nutrients. Glucose is added as the primary 
food source, calcium chloride as a sodium source, magnesium sulfate for DNA replication, and 
casamino acids provide a nitrogen source for amino acid production. Per previous protocols, 
20% w/v glucose and casamino acids are added, while 1M magnesium sulfate and calcium 
chloride are used. UFAs are added at a concentration of 300µM, based on previous research [24]. 
                                                        
1 Full protocols are available in the Appendix. 
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3.2 Growth Curves 
Growth curves are performed in order to mark the four main phases of a bacteria’s growth. 
Cells initially enter into a lag phase in which they begin to grow and reproduce. Here, growth 
may be slow due to low initial population density or poor physiological adaptation to the growth 
medium.  They then go through an exponential phase in which growth and replication vastly 
outweigh cell death. Stationary phase, the third phase, occurs when the rate of new cell formation 
roughly equals the rate of cell death. Finally, death phase occurs when either all nutrients within 
the media have been used or waste accumulation has become toxic to the cells. Growth curves 
must be done initially to understand the growth patterns of a specific bacteria. Once this is 
understood, further assays can be tailored to these bacteria based upon their growth phases. 
Growth curves are performed by growing bacteria in a flask or bioreactor and taking optical 
density readings at 600nm (OD600) at preset time increments. The OD600 value is a measure of 
the concentration of bacteria present in the culture by passing a wavelength through a sample of 
the culture in a cuvette to measure the turbidity of the sample. These OD600 values are recorded 
every 30 minutes and plotted to visualize the growth phases of the bacteria. Typically, lag phase 
occurs up to an OD600 of 0.2, while exponential growth typically occurs around 0.2 – 2.5. Most 
growth curves are performed to define this range for assay development; culture sampling is 
done in the exponential phase so bacteria will continue to grow and multiply to produce the 
phenotypic traits being sampled for. Stationary phase typically occurs at 2.5 where bacteria are 
no longer fit for sampling due to increased cell death and nutrient depletion. Death phase occurs 
similarly occurs once the OD600 begins to drop from 2.5 at the stationary phase at and the culture 
is no longer fit for study. 
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3.3 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA is an assay typically used to detect proteins, peptides, and antibodies, and can be used 
to detect cholera toxin. In this assay, V. cholerae cultures are grown in hydrophobically-coated 
96-well plates that have been coated to block all non-specific binding sites. Figure 3 below 
shows the antibody interaction used.  
 
Figure 3. Substrate complex utilized in an ELISA assay [25] 
The plate is then coated with a ‘capture antibody’, pictured in green, that allows for specific 
binding with CTX. The culture is then added and any CTX present, yellow, can bind to the 
capture antibody. The plate is then washed to rid it of any unbound antigen. Typically, a specific 
antibody, blue, is added that binds to CTX, sandwiching it, and then a detection antibody, purple, 
is added that binds to the specific antibody. Lastly, a substrate is added that reacts with the 
detection antibody to change colors. After approximately 20 minutes, the color-changing 
reaction is stopped with sulfuric acid. The color vibrancy is then measured in a plate reader to 
quantitatively measure the amount of CTX produced. The deeper the color, the more CTX 
available for antibodies to bind with [25]. The plate configuration can be seen below in Figure 4. 
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      Figure 4. 96-well ELISA plate layout 
In the assay developed, overnight cultures are grown for 18 hours at the chosen 
environmental condition. The plate used is coated in Superblock Blocking Buffer which is an 
optimized PBS and TBS solution that contains a blocking protein. This is done to inhibit non-
specific binding and minimize signal noise. GM1, a known binding receptor for CTX, is then 
added for capture [26]. A horseradish peroxidase (HRP)-conjugated CTX antibody is then added 
to bind to any CTX present, with the HRP enzyme being necessary for catalyzing the color 
change once TMB is added. This TMB-facilitated color change is stopped with sulfuric acid after 
20 minutes. The plate is then read at both 550 and 540 nm and the final absorbance reading is the 
difference between them, in order to account for optical imperfections in the microtiter plate. 
The culture added in columns 2 – 7 is taken at an OD600 of 0.6 and contains an unknown 
amount of cholera toxin produced. Rows 8 – 11 contain a known concentration of toxin that is 
added to develop a calibration curve. By graphing these known concentrations against the 
absorbance readings obtained, an equation can be developed to back calculate the unknown toxin 
concentrations produced by the six rows with no added CTX. To test the effects of UFAs on 
toxin production, the second row contains culture with no exogenous UFAs present and the next 
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four rows each contain one UFA of interest. Media is plated in the four corners of the plate to 
measure for any contamination that could have occurred throughout the experiment. If growth is 
seen in any of the four wells, the data can be deemed unreliable. PBS is added in the same rows 
and columns as the media to reduce the edge effect. This effect occurs when some of the media 
or culture in the perimeter of a plate evaporates during incubation. This results in unreliable data 
due to varying concentrations and volumes, leading to erratic absorbance readings. 
3.4 Biofilm Formation 
 Biofilm formation can be measured quantitatively by growing bacteria in a 96-well plate in 
the presence or absence of UFAs. Overnights are grown in the chosen media at the desired 
conditions (human host or marine environment). After overnights have grown for 18 hours, they 
are removed from the shaking incubator and centrifuged to separate the bacterial cells (the pellet) 
from the media (the supernatant). Five microcentrifuge tubes of the resuspended pellet culture 
and media are all started at an OD600 of 0.2. One UFA is added to each tube while one tube with 
no fatty acid serves as a control. These five tubes are used to inoculate a 96-well plate with 
200uL in each well as shown below. PBS and media are used around the perimeter as described 
previously.  
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    Figure 5. 96-well biofilm plate layout 
 
 After the culture has been plated, it is allowed to grow for 24 hours at the desired conditions. 
The culture is then removed from the plate and the plate is washed to remove any remaining 
planktonic cells. After washing, only the biofilm formed by the culture within the 24-hour period 
will be left along the sides of each well. This is then stained with crystal violet, emptied and 
washed, and allowed to dry for another 24 hours. Lastly, the stained biofilm is solubilized with 
30% (w/v) acetic acid, transferred to a fresh microtiter plate, and read using a plate reader. The 
higher the absorbance, the more biofilm that was formed. 
3.5 Antibiotic Resistance 
Overnight cultures for the antibiotic resistance assay are grown and pelleted similarly to the 
biofilm assay. The inoculum is be started at an OD600 of 0.1 to obtain cells in the beginning of 
the exponential phase. Instead of plating them immediately, test tubes are incubated in the 
presence of one UFA each with one negative control to see the potential membrane remodeling 
that occurs with UFA uptake and the subsequent effect on antibiotic resistance. The antibiotic 
administered in this assay, polymyxin B, is commonly used to treat infections involving Gram-
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negative bacteria and interferes with the cytoplasmic membrane of the cell. This is added to the 
plate, shown below, in two-fold increasing amounts in order to find the minimum inhibitory 
concentration, the lowest amount of antibiotic that inhibits bacterial growth.  
 
Figure 6. 96-well antibiotic resistance plate layout 
In the plate, 30uL of each antibiotic concentration is added along with the appropriate UFA 
(or none) and 170uL of culture. This is allowed to grow for 20 hours in the shaking incubator at 
the desired conditions and then the plate is read at 600nm, for a typical OD600 growth reading. 
By comparing each fatty acid row with the control group, the effect of each UFA on antibiotic 
resistance can be seen. The higher the growth in a well, the more antibiotic resistance the culture 
in that well has acquired, potentially due to membrane remodeling via UFA uptake.
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Chapter 4. Preliminary Experimental Data 
4.1 Growth Curve 
4.1.1 Human Host, 37ºC 
As V. cholerae is largely dormant in oceanic conditions, a growth curve was only performed at 
human host conditions. This data can be seen below in Figure 7. 
 
 Figure 7. V. cholerae growth curve 
This growth curve shows the first three phases of cell growth: lag, exponential, and stationary. 
The initial optical density of 1.4 is the inoculum culture. The absorbance then significantly 
lowers as the bacteria become accustomed to the new media. The growth curve experiment was 
performed in order to verify that temperature and pH could be monitored and controlled in the 
bioreactor, and to determine the optical density range corresponding to exponential growth for 
subsequent assays. For example, the test tubes in the antibiotic resistance assay needed to be 
started at the beginning of the exponential phase for optimal UFA uptake. After performing a 
growth curve, this was determined to be 0.1. Similarly, this curve validated that an OD of 0.6 is 
still in exponential phase, used in the assay for toxin production. 
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4.2 ELISA 
4.2.1 Human Host, 37ºC 
 Preliminary data for CTX production in M9 was gathered for qualitative analysis. Initially, in 
the four columns with no added CTX, culture was pulled and used at ODs of 0.2, 0.4, and ~ 0.6 
in three columns. This was done to confirm the optimum cell density as 0.6 for measurable, 
consistent toxin production data. In this trial, three different antibody concentrations were used 
as well to establish the necessary dilution for optimum binding. A dilution of 1:500 was 
ultimately used based upon published protocols. Similarly, it gave the most consistent 
absorbance readings. This preliminary data can be seen below in Figure 8. 
 
Figure 8. Preliminary ELISA data 
This data was not used to calculate the amount of CTX produced, but simply to demonstrate the 
feasibility of the assay in our hands and ensure that CTX production could be observed in M9. 
Data on CTX production in the literature was only reported under virulence-inducing conditions. 
These assays were used to show the protocol was viable, but as the process took around 13 
hours, it was determined that quantitative data for this assay needed to be gathered at a later date.  
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4.3 Biofilm Formation 
4.3.1 Human Host, 37ºC 
 Tests for biofilm formation were conducted in CM9 and HEPES. This shows the effect of 
additives on biofilm formation as well as the significance of pH control. Preliminary data 
gathered for biofilm formation in CM9 can be seen below in Figure 9. 
 
Figure 9. Biofilm Formation in CM9 at 37ºC 
At 37ºC and 150mM NaCl, UFAs lowered the amount of biofilm produced in V. cholerae. 
Biofilm formation is reduced more significantly, by half, in the presence of 18:2, which agrees 
with previous studies [24].  
 Biofilm formation at the same conditions, but at a constant pH of 7.2 using HEPES, was 
significantly different. This could suggest that pH has a significant effect of biofilm production. 
This can be seen below in Figure 10. 
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Figure 10. Biofilm Formation in HEPES at 37ºC 
This preliminary data shows that 18:2 nearly quintuples biofilm formation, while 20:5 does so 
less significantly. This trend suggests that a lower pH increases biofilm formation, which also 
agrees with literature. Similarly, biofilm formation is important in the human host for adherence 
to the small intestine, where pH ranges from 6.0-7.2. This data suggests that environment-
specific fatty acids and pH act synergistically to trigger the virulence cascade. 
4.3.2 Oceanic Conditions, 30ºC 
 Preliminary data for biofilm formation in marine conditions can be seen below in Figure 11. 
 
Figure 11. Biofilm Formation in CM9 at 30ºC 
From this data, 18:2, 20:4, and 22:6 seem to have no effect on biofilm production at 30ºC and 
300mM NaCl while 20:5 lowered production. This could suggest that 20:5 is constitutively 
 
 
23 
diffused through V. cholerae’s membrane to behave as a signaling molecule as it causes a change 
in biofilm formation at each environmental condition and in each media.  
4.4 Antibiotic Resistance 
4.4.1 Human Host, 37ºC 
 Minimum inhibitory concentrations (MIC) for polymixin B were determined in CM9. The 
preliminary data below shows the antibiotic resistance at various antibiotic concentrations at 
37ºC and 150mM. 
 
Figure 12. Antibiotic Resistance at 37ºC 
Table 1 below gives the minimum inhibitory concentration of polymixin B for V. cholerae 
growth at these conditions.  
Table 1. MIC of polymixin B at host conditions 
CULTURE MIC (µG/ML) 
CONTROL 1280 
18:2 640 
20:4 640 
20:5 160 
22:6 160 
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The presence of any fatty acid lowers the MIC with respect to the control. In these conditions, 
18:2 and 20:4 result in a two-fold decrease, while 20:5 and 22:6 result in a six-fold decrease in 
MIC.  
4.4.2 Oceanic Conditions, 30ºC 
 Figure 13 below shows antibiotic resistance in V. cholerae at 30ºC and 300mM NaCl. This 
assay was done at an osmolarity of 300mM, not 600mM, based upon old data. Although this data 
cannot be used to quantify brackish water, it could be used as an intermediary osmolarity and to 
verify the protocol. 
 
 
Figure 13.  Antibiotic Resistance at 30ºC 
Table 2 below shows the minimum inhibitory concentrations of polymixin B for V. cholerae 
growth at oceanic conditions. 
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Table 2. MIC of polymixin B at marine conditions 
CULTURE MIC (µG/ML) 
CONTROL 2560 
18:2 1280 
20:4 2560 
20:5 640 
22:6 320 
 
The MIC is noticeably lowered by the presence of each fatty acid at aquatic conditions of 30℃ 
and 300mM salinity, except 18:2 and 20:4. 22:6 has the highest inhibitory effect on the minimum 
inhibitory concentration for PMB with a six-fold decrease, while 20:4 has a minimal effect with 
no change in MIC. 18:2 resulted in a two-fold decrease and 20:5 gave a four-fold decrease in 
MIC. Because 18:2 and 20:4 had little to no effect in saltwater conditions but lowered MIC in 
host conditions, V. cholerae may only uptake these UFAs at host conditions or there is another 
variable controlling the use of these fatty acids. As 20:5 and 22:6 lower antibiotic resistance in 
both environmental conditions, V. cholerae could constitutively use them to modulate antibiotic 
resistance. 
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Chapter 5. Regulatory Systems 
5.1 Background Information 
Gene regulation allows bacteria to maintain biochemical flexibility while optimizing energy 
efficiency. While bacteria carry all of the genetic information for synthesizing many proteins, 
only a subset of this information is expressed at any time. An operon, shown below in Figure 14, 
is a group of bacterial structural genes that are transcribed as a group to optimize protein 
synthesis. Essentially, an operon controls the conversion of other genes into a product to be 
expressed.  
 
    Figure 14. General operon schematic [27] 
The regulator gene helps control the expression of structural genes of the operon by increasing or 
decreasing their transcription but is not considered part of the operon.  The promoter is the 
region of DNA where RNA Polymerase binds to begin transcription. The operator is a region 
preceding the operon, overlapping the promoter, where regulatory can protein bind to affect 
transcription. The structural genes code for various proteins. This is essential to a cell in order to 
respond to environment-specific needs, instead of constantly producing these proteins, even 
when unnecessary.  
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 Transcriptional regulation can be positive or negative. In positive control, a regulatory 
protein is an activator that stimulates transcription. In negative control, a regulatory protein acts 
as a repressor, binding to DNA and stopping transcription. By binding to the operator, the 
promoter is blocked by the repressor, RNA polymerase is unable to bind to the DNA, and no 
genetic information is transcribed. Likewise, expression of a gene or protein can be constitutive, 
or always expressed. 
 Gene expression can also be controlled by the available nutrients. Catabolite repression is the 
process in which genes that participate in the metabolism of other sugars are turned off when 
glucose is present. This occurs because glucose requires less energy to metabolize; therefore, 
when available, glucose is preferentially used as an energy source. The catabolite activator 
protein complexes with the nucleotide cAMP and together they stimulate transcription. The 
concentration of cAMP is regulated within the cell so that it is inversely proportional to the 
available glucose. Thus, when glucose is available, there is less cAMP available to complex and 
minimal transcription occurs. This further allows bacteria to respond to the surrounding 
environment. 
5.2 Gene Expression in Vibrio cholerae 
Gene expression in V. cholerae can be seen below in Figure 15. Ovals represent proteins and 
porins while pentagons represent genes. Table 3 below shows what each protein regulates and 
what each gene codes for.  
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           Figure 15. V. cholerae regulatory networks 
 
 
Table 3. V. cholerae regulatory factors 
Transcriptional Regulatory proteins 
ToxRS Cholera toxin master regulator 
TcpPH Toxin coregulated pilus master regulator 
AphAB TcpPH regulator 
OmpU Outer membrane porin 
OmpT Outer membrane porin 
ToxT Cholera toxin regulator 
VolA Outer surface lipoprotein 
FadL Fatty acid transport 
FadD Fatty acid activator 
FadR Fatty acid regulator 
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Structural Genes 
toxRS ToxRS proteins 
tcpPH TcpPH proteins 
aphAB AphAB proteins 
tcpI TcpPH inner membrane localization 
tcpA-F TCP precursors 
acf Accessory colonization factors 
toxT ToxT protein 
ctxAB Cholera toxin 
fadBEH Fatty acid degradation 
plsB Phospholipid biosynthesis 
fabAB UFA biosynthesis 
fabHF SFA biosynthesis 
 
V. cholerae has two major types: pathogenic and non-pathogenic. It is theorized that the 
pathogenic strains evolved from their aquatic, non-pathogenic counterparts through the 
progressive acquisition of virulent traits. This evolution eventually gave them the ability to 
colonize the human host while simultaneously retaining marine fitness. The acquisition crucial to 
the evolution of virulence was the cluster of genes stretching from tcpI to acf called the Vibrio 
pathogenicity island (VPI). V. cholerae was able to attain the VPI via horizontal gene transfer, 
which is the transfer of genetic material from cellular organisms of different species, not from 
parent to offspring. These genes were attained by the bacteria before many of the proteins shown 
in figure 15 [28].  
Virulence in V. cholerae is controlled mainly by two transcriptional activators, ToxR and 
TcpP, via the upregulation or downregulation of ToxT. ToxR, the main regulatory protein, was 
the first positive regulator discovered in V. cholerae and spans the inner membrane. ToxS, a 
secondary regulatory protein, is crucial for the function of ToxR, although it is unknown why; 
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however, it is hypothesized that ToxS may help stabilize ToxR. ToxRS regulate OmpU and 
OmpT, two outer membrane porins that provide stress resistance when triggered by certain 
environmental cues [29, 30].  
TcpP, the regulatory protein that enables the gene for the toxin coregulated pilus, is also a 
transmembrane protein that requires a secondary transcriptional activator, TcpH. This is 
theorized to be used in the same way as ToxS. Without TcpH, TcpP is degraded. While ToxR 
and TcpP are both necessary for the activation of ToxT, ToxR serves as an enhancer to enable 
TcpP to bind with RNA Polymerase to activate transcription. Membrane localization of ToxR is 
mandatory for its interaction with TcpP. While the ToxRS proteins are found in all strains of V. 
cholerae and are constitutively expressed, TcpPH are found only in pathogenic strains, further 
verifying that TcpP is the primary transcriptional activator of ToxT [30-32]. TcpPH are regulated 
by activators AphA and AphB. AphB is a secondary effector similar to ToxS and TcpH. AphAB 
bind to TcpP and activate the protein. AphA is also used for quorum sensing, which allows a 
bacterium to detect the surrounding population density and vary virulence accordingly. In this 
regard, it upregulates biofilm formation [21, 30].  
Cholera toxin, encoded by the ctxAB gene, is regulated by ToxT. This cytoplasmic protein is 
essentially at the end of the regulatory cascade responsible for V. cholerae virulence. ToxT binds 
to the promoter upstream of ctxAB, tcpA-F and acf. The regulatory pathway of these genes can 
be seen below in Figure 16, where an arrowhead represents upregulation and a dash represents 
downregulation. 
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Figure 16. ToxR regulatory cascade 
This is the regulatory cascade of V. cholerae with no external effects. Due to the bacterium’s 
ability to uptake exogeneous fatty acids and responds to environmental cues, this changes 
between environments. This will be discussed in the next section. 
ToxR is required for the expression of OmpU, while ToxR represses OmpT. It has been 
shown that OmpU may also serve as an adhesin, binding to fibronectin and arginine-glycine-
asparagine (RGD) tripeptide. Fibronectin can serve in eukaryotic extracellular matrices, such as 
epithelial cells, as a bridge to extracellular proteins, like porins in V. cholerae. The RGD 
tripeptide is the key factor that mediates cell-to-cell adhesion and interaction via integrins, 
ligands, and fibronectin in the extracellular matrix. The selective binding of OmpU to these 
factors suggests that this protein assists in V. cholerae binding to eukaryotic cells for infection. 
Furthermore, this coincides with the upregulation of this protein according to ToxRS; V. 
cholerae must be attached to host cells to cause infection with the expression of virulence 
factors, also upregulated by ToxRS. OmpT, however, is repressed by ToxRS. The variation in 
regulation of OmpU and OmpT is due to their different selectivities; OmpT facilitates passage of 
negatively charged cations, such as bile or other detergents. With unregulated influx, these 
cations would disrupt the cytoplasmic membrane and lower growth rates. OmpU is much more 
selective in passage, explaining why this porin is upregulated via the virulence cascade while 
OmpT is repressed [33, 34]. 
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 Recent V. cholerae genomic studies have revolved around the fatty acid degradation cascade 
including FadL, FadD, and FadR. FadL is a long-chain fatty acid transporter spanning the outer 
membrane and is coexpressed with VolA, which aids in uptake of exogenous 
lysophosphatidylcholines. FadD is a long chain fatty acyl-CoA ligase, which activates long chain 
fatty acids to be used for phospholipid synthesis. FadR is the master regulator of fatty acids, 
controlling FA biosynthesis, degradation, and phospholipid biosynthesis [35, 36]. Figure 17 
shows this regulation. 
 
  Figure 17. Fatty acid regulatory cascade 
Without environmental interaction, FadR downregulates phospholipid biosynthesis and fatty 
acid degradation while stimulating saturated and unsaturated fatty acid biosynthesis. Interaction 
with long chain fatty acids (LCFA) disrupts this regulation. Therefore, as FadR is only active 
when no LCFA has been imported, it is imperative that the bacteria be able to synthesize its own 
fatty acids and not degrade them. These fatty acids are used to synthesize the phospholipids 
necessary for the cell membrane. FadR regulates these genes by binding directly to their 
promoters. FadR and FadD both upregulate ToxT but do so independently of one another [36]. 
This is not done via ToxR but through another unknown mechanism. Although FadD does not 
alter ToxR or TcpP production, it is necessary for TcpP membrane localization. The absence of 
FadD induces the extracytoplasmic stress response (ESR), which is one way in which bacteria 
sense the changing environment. The ESR responds to changes in the cell membrane, such as the 
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absence of a particular membrane protein, FadD. This response ultimately activates an integral 
membrane protease that degrades TcpP, which in turn decreases other virulence genes [32, 37]. 
 Lipopolysaccharides, comprising the outer leaflet of the outer membrane, successfully allow 
for the diffusion of short chain fatty acids while blocking long chain fatty acids in bacteria. 
Therefore, the presence of FadL is required for transport into the bacterial cell [38]. In the 
absence of external factors, FadR represses FadL. As FadR upregulates FA synthesis and 
downregulates FA degradation, expression of FadL is unnecessary since fatty acids are already 
being synthesized de novo. 
5.3 Environmental Cues 
  In response to a changing environment, V. cholerae must adapt in the presence of various 
cues. These markers include pH, temperature, salinity, and fatty acids. In the main virulence 
cascade, the ToxR regulon, exogenous unsaturated fatty acids act as configurational repressor by 
binding to ToxT in the place of ToxR, disabling the structural genes encoding toxin, the pilus, 
and other colonization factors [29]. This is shown below.  
 
Figure 18. Change in the ToxR regulon with UFAs 
Commonly, these UFAs are introduced in the human host within bile. As previously discussed, 
bile represses biofilm formation and toxin production. By repressing ToxT during the early 
stages of infection, V. cholerae can maximize energy efficiency in gene expression by repressing 
factors unnecessary to initial epithelial penetration. In the presence of bile, the repression of 
OmpT is critical. If OmpT were not repressed, excess amounts of bile would be transported into 
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the cytoplasmic membrane, stopping growth by simultaneously competing with nutrient entry 
and damaging the inner membrane. However, with OmpT repressed and OmpU expressed, bile 
acids are selectively excluded from membrane diffusion, allowing bacteria to survive entrance 
into the small intestine. It has been shown that strains expressing OmpU are more bile-resistant, 
pathogenic, and better able to colonize the small intestine than those expressing OmpT. This 
regulation increases antibiotic resistance simply as less pores are open for antibiotic diffusion. 
[33, 34].  
 Unsaturated fatty acids are introduced in the marine environment within the reservoirs used 
by V. cholerae. The repression of virulence via these marine UFAs is similarly important; 
production of virulence genes is a waste of energy as there is no host to infect at this point. 
Likewise, the repression of OmpT is critical due to the high salinity of the ocean. If OmpT were 
to be open, the cell would ultimately become hypotonic and lyse due to the constant influx of 
sodium chloride resulting in a high osmotic pressure.   
Lysophosphatidylcholines (LPCs) are long chain chemical compounds with a choline head 
group and a variable fatty acid chain at one end. VolA, a lipoprotein located on the outer surface 
of the outer cell membrane that is coexpressed with FadL, cleaves the fatty acid chain off of 
these exogeneous LPCs. This allows FadL to transport this free fatty acid into the bacterial cell. 
This fatty acid must initially cross the periplasm, but must also reach FadD, located on the inner 
layer of the inner membrane’s phospholipid bilayer. To do this, it must first be transported 
through the first leaflet. The mechanism by which this occurs is unknown [35, 39]. Once through 
the periplasm and the inner cell membrane, FadD activates this long chain fatty acid (LCFA) 
with an acyl-CoA, and this complex represses FadR [36]. This can be seen below in Figure 19. 
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Figure 19. Change in fatty acid regulation with exogenous LCFA uptake 
 By repressing FadR, both short and long UFA synthesis is turned off, while phospholipid 
biosynthesis and fatty acid degradation is turned on. As this repression occurs when fatty acids 
have been imported into the cell, fatty acid biosynthesis is unnecessary and an energy waste. 
Opposingly, in the presence of these LCFAs, fatty acid degradation is turned on along with 
phospholipid synthesis. Thus, as these LCFAs are imported into the cell, V. cholerae can now 
degrade them for energy and use them for the phospholipid bilayer. As FadR is repressed, it’s 
influence on ToxT is downregulated. Nonetheless, because ToxT is affected by FadR and FadD 
independently, it is still upregulated by FadD.  
The uptake of these LPC-derived fatty acids is equally important in both environments. 
Within the human host, these chemical compounds can be found in the lumen of the small 
intestine. Due to the cleaving action of VolA, V. cholerae can use the newly freed fatty acids for 
membrane remodeling similarly to the action of unsaturated fatty acids. This membrane 
remodeling can allow the bacteria to survive subsequent membrane stress. In the aquatic 
environment, LPCs can be found in association with the bacteria’s reservoirs. Here, they can 
similarly use the cleaved LCFA for membrane remodeling, but it has also been shown that V. 
cholerae can use LPCs as its sole carbon source. While in the brackish waters, nutrient 
deprivation is prevalent. Using LPCs as a carbon source allows the bacteria to become more fit 
and survive without entering the VBNC state [13, 20, 35]. 
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Chapter 6. Conclusions and Future Work 
6.1 Conclusions 
 This research demonstrates the viability of several protocols as well as preliminary insights 
into Vibrio cholerae’s phenotypic traits. Through the development of protocols, assays were 
tailored to V. cholerae using various medias, the addition of unsaturated fatty acids, and two 
environmental niches. A nutritionally rich medium was initially used for feasibility trials. To 
begin identifying key environmental triggers, assays were conducted using minimal media. The 
final media used, HEPES, offers pH stability throughout the growth of bacteria. Four UFAs were 
used: linoleic and arachidonic acids to represent the human host and eicosapentaenoic and 
docosahexaenoic acids to represent brackish waters.  
 It was shown that cholera toxin could be produced and quantified in non-virulence inducing 
conditions, whereas CTX production has been previously published only in virulent conditions. 
The protocol was tested to show that an OD600 of 0.6 was optimal for toxin production in these 
conditions and an antibody dilution of 1:500 was ideal for toxin capture. 
 Biofilm formation data was gathered in three conditions: with minimal media in both 
environmental niches and with HEPES in host conditions. It was shown that host conditions 
supplemented with 18:2 had the largest impact, while marine conditions had very little impact. 
This could potentially mean that V. cholerae only uptakes this UFA to use as a signaling 
molecule in the human host. As linoleic acid is found in human bile, this is a logical conclusion. 
Furthermore, the variation of 18:2-induced biofilm change with pH is vast. In minimal media, 
each UFA lowered biofilm formation, with 18:2 doing so by half. In HEPES, where pH is held 
constant, each UFA increased biofilm formation, with 18:2 doing so by five-fold. This could 
potentially signify that pH and unsaturated fatty acids synergistically alter the virulence cascade 
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within V. cholerae. According to published work, a lower pH increases biofilm formation, which 
agrees with this data. Therefore, V. cholerae is theoretically more adapted to the human host 
where pH ranges from 6.0 – 7.2, allowing it to use biofilm to both protect against membrane 
stress within the host and colonize the small intestine. In marine conditions, eicosapentaenoic 
acid (20:5) was the only unsaturated fatty acid that changed biofilm formation. 20:5 affected 
biofilm in both conditions, suggesting that it could diffuse through V. cholerae’s membrane to be 
used as a signaling molecule within the virulence cascade regardless of the surrounding 
environment. 
 By measuring the MIC of polymixin B, environment-specific effects relating to antibiotic 
activity could be evaluated. In host conditions, all unsaturated fatty acids lowered antibiotic 
resistance, with the 20:5 and 22:6 doing so by six-fold. In marine conditions, 20:4 had no effect, 
18:2 and 20:5 had little effect, and 22:6 had a large effect on antibiotic resistance, again lowering 
the MIC by six-fold. As 18:2 and 20:4 had little to no effect in this environment but lowered 
MIC in host conditions, V. cholerae may only use these UFAs for membrane remodeling in the 
human body. Because 20:5 and 22:6 lowered antibiotic resistance in both environments, these 
may be constitutively used for membrane remodeling. 
 Bacteria are an ever-evolving domain, as evidenced by the Vibrio pathogenicity island. As 
we continue to develop means of fighting these infections, bacteria are able to adapt and evolve 
resistance against them. Bacterial antibiotic resistance is considered one of the greatest threats to 
human health. Beginning as a single mutation, a bacterium can rapidly develop mechanisms to 
survive a course of antibiotics; upon survival, it is able to reproduce and pass on this acquired 
resistance. As V. cholerae acquires these persistent traits, medicine begins falling behind. The 
WHO 2014 report stated "this serious threat is no longer a prediction for the future, it is 
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happening right now in every region of the world and has the potential to affect anyone, of any 
age, in any country. Antibiotic resistance—when bacteria change so antibiotics no longer work 
in people who need them to treat infections—is now a major threat to public health." In 2015 
there were almost 700,000 infections were caused by antibiotic resistant bacteria [40]. Simply 
put, medicine isn’t developing as fast as bacteria are.  
 The quantification of changes in antibiotic resistance poses an important potential benefit to 
modern medicine. By measuring the effects of unsaturated fatty acids on antibiotic resistance, 
they could potentially be incorporated within antibiotics. For example, in this research it was 
seen that docosahexaenoic acid lowers antibiotic resistance by six-fold in both brackish waters 
and the human host. Theoretically, this unsaturated fatty acid could be used synergistically with 
antibiotics, lowering resistance in the infecting bacteria. This application is not only germane to 
V. cholerae; it has been shown that several more bacteria possess the ability to uptake exogenous 
fatty acids [24]. This gives the potential to fight a whole class of resistant bacteria by a new 
means. 
 By understanding the regulatory networks of V. cholerae, specific proteins or genes can be 
identified as key points in the cascade. If virulence can be attributed to specific proteins, genetic 
recombination techniques could be developed to up or downregulate them. For example, it was 
shown that OmpT in V. cholerae is downregulated for selective diffusivity. If OmpT were 
upregulated, bile would flow in upon ingestion, resulting in cell death; infection would not occur. 
By studying bacterial genes and their regulatory networks, alternative treatments can be 
developed. 
The Fad regulon has been identified in many bacteria and characterized in E. coli; however, 
V. cholerae’s ability to uptake long chain fatty acids to use for membrane remodeling has not 
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typically been seen in other Gram-negative bacteria. Although the Fad regulon has been 
classified in other bacteria, V. cholerae possesses multiple homologs of FadD and FadL [32]. 
This allows the bacteria to recognize and uptake a variety of fatty acids, ultimately allowing 
adaptation to multiple environments. 
6.2 Future Work 
Due to the inaccuracies of observed when assessing phenotypic traits, research will begin 
centering around proteomic and genomic studies. When testing phenotypes, only an end product 
is measured. Due to this, the independent variable could be affecting the expression of this 
physical characteristic at any point in the regulatory cascade. For example, when testing the 
effect of unsaturated fatty acids on toxin production, it is difficult to ascertain the true result in 
the assays developed; either AphA, ToxR, TcpP, or ToxT could be downregulated due to the 
introduction of UFAs. The only information available is the increase or decrease in CTX 
production. This prompted a shift in focus to genotypic studies. 
With the awarding of a CEACSE grant, research will move towards the development of a 
computational framework to model V. cholerae’s fundamental pathogen dynamics. This will be 
backed with laboratory experiments to represent various ecological and environmental 
conditions. Combined molecular modeling will reveal information regarding the pathogenesis 
and transmission of waterborne pathogens.  
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Chapter 7. Materials and Methods 
7.1 Bacterial Strain 
Throughout these experiments, Vibrio cholerae strain C6707 was used. O1 El Tor classical 
biotype is an epidemic strain.  
7.2 Growth Conditions 
Granulated LB was obtained from Fisher Scientific. 25 g of this broth was dissolved in 1 L of 
sterile DI water.  
M9 salts were similarly obtained from Fisher Scientific as a 5x. 28.2 g of M9 salts were 
dissolved in 500 mL sterile DI water and 20.67 g of NaCl added for a 0.75M solution (host) or 
86.41 g is added for a 3.0M solution (marine). This was diluted to a 1x solution with sterile DI 
water to attain M9 with 150mM or 600mM salinity. 
HEPES must be made at the correct pH and the temperature at which it was made must be 
accounted for. 200mL of 0.25M stock solution (5.55x) was stored. For host conditions, this was 
made by dissolving 11.915g of HEPES in 180mL of sterile DI water and titrated to a pH of 7.43 
at room temperature of 25ºC. The volume was then brought to 200mL. At the experimental 
temperature of 37ºC, the pH held at 7.2. 9.74g of NaCl was added for a final diluted salinity of 
150mM. The solution used is was 45mM HEPES solution made by diluting the stock with sterile 
DI water.  
For a HEPES media appropriate for oceanic conditions, 11.915g of HEPES was dissolved in 
180mL of sterile DI water and titrated to a pH of 8.07 at room temperature of 25ºC. This solution 
was brought to a total volume of 200mL and 38.96g of NaCl to give a 600mM solution upon 
dilution to the 45mM 1x HEPES solution. 
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In each media, supplemental nutrients were provided. Filter sterilized stock solutions stored 
include: 20% (w/v) C6H12O6, 1M MgSO4, 1M CaCl2, and 20% CAA. These were then added to 
the media for growth. Final concentrations of each additive in each media were as follows: 2% 
C6H12O6, 0.2% MgSO4, 0.02% CaCl2, and 1% CAA (v/v). The unsaturated fatty acids are added 
at a concentration of 300mM. 
7.3 ELISA 
7.3.1 ELISA Materials 
The GM1 dilution in this assay was made by diluting 1mg of the ganglioside in 1mL of water. 
PBS/Tween was made as a dilution of 0.1% Tween, 100µL, in 100mL of PBS. 0.5mg of cholera 
toxin was diluted in 0.5mL of sterile DI water, made from a 2mg/mL vial of CTX. HRP was 
diluted with 0.1% BSA in PBS (w/v). 0.2M H2SO4 was used to stop the enzymatic reaction. 
The 96-well plates used were clear polystyrene coated in Immulon 1B for hydrophobic binding.  
7.3.2 ELISA Protocol 
1) Create 1 overnight culture to shake at 250rpm at the desired temperature  
a. Create 1 tube of media only to serve as a control for contamination 
2) After 16-20 hours, use the overnight culture to inoculate 100mL of media in an Erlenmeyer 
flask 
3) Record the initial OD600 and continue to shake the flask at the desired temperature 
4) Sample the culture every 30 minutes until it has reached an OD600 of 0.6 
5) Centrifuge the sample in a 15mL conical with a balance for 10 min at 6000rpm 
6) Allow all reagents and plates to sit out to room temperature for at least 30 min 
7) Label the UV sterilized coated 96-well microtiter plate 
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8) Add 150µL of blocking buffer to each well, cover plate, and allow to sit at room temperature 
for 1 hour 
9) Wash the plate three times with PBS/Tween 
10) Add 100µL of supernatant at OD 0.6 in rows 2 – 7 
11) Add 100µL of CT control at all 4 concentrations in rows 8 - 11 
12) Cover and incubate at the desired temperature for 1 hour 
13) Wash the plate three times with PBS/Tween 
14) Add 100µL of the Polyclonal Antibody at a concentration of 1:500 and incubate at the 
desired temperature for 1 hours  
15) Wash the plate three times with PBS/Tween 
16) Add 100µL of the TMB to each well 
17) Incubate at room temperature until color appears in the positive controls (10-20min) 
18) Stop the reaction with 50µL of 0.2M H2SO4. 
19) Read the plate at 550nm and 450nm 
20) Calculate the final absorbance as the difference of the two readings 
7.4 Biofilm Formation 
7.4.1 Biofilm Assay Materials 
A 0.1% (w/v) crystal violet solution was used to stain the biofilm. A stock 5x solution was made 
by dissolving 5mg of CV powder in 5mL of water in a light-blocking container. The stained 
biofilm was solubilized with 30% acetic acid. The 96-well plate used was clear polystyrene. 
7.4.2 Biofilm Formation Protocol2 
1) Create 2 overnight cultures to shake at 250rpm at the desired temperature  
                                                        
2 This protocol was adapted from O’Toole’s biofilm assay [41] 
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a. Create 1 tube of media only to serve as a control for contamination 
2) After 16-20 hours, remove the overnight cultures and pour the overnights into a 15mL 
conical, place in centrifuge, balance, and spin for 10 minutes at 4500rpm 
a. Create five 2mL micro centrifuge tubes labeled ‘-’, ‘18:2’, ‘20:4’, ‘20:5’, and ‘22:6’ 
3) Once complete, pour off the supernatant and refill the tubes with 1 mL of media, carefully as 
to not disrupt the pellet, and spin for 10 minutes at 4500 rpm  
a. Replace these in the centrifuge with the pellet facing upward 
b. Add 300mM of each UFA to the corresponding microcentrifuge tube 
FATTY ACID VOLUME (µL) 
18:2 0.248 
20:4 0.843 
20:5 0.843 
22:6 0.909 
 
4) Once complete, pour off supernatant and re-suspend in 1 mL media 
a. This is done by breaking up the pellet with the media and pipette 
5) Measure the OD600 of the prepared inoculum 
6) Calculate the volume of culture required to start the microcentrifuge tubes at an OD of 0.1, 
according to the equation below 
(𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑣𝑜𝑙𝑢𝑚𝑒)(𝜇𝐿) = 	 (𝑑𝑒𝑠𝑖𝑟𝑒𝑑	𝑂𝐷)(𝑡𝑜𝑡𝑎𝑙	𝑣𝑜𝑙𝑢𝑚𝑒)(𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑂𝐷) ∗ 1000 
7) Place a total volume of 1.8 mL in each microcentrifuge tube, culture added last, calculating 
the amount of media to be added as follows: 𝑀𝑒𝑑𝑖𝑎	(𝜇𝐿) = 1800 − (𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑣𝑜𝑙𝑢𝑚𝑒) − (𝐹𝐴	𝑣𝑜𝑙𝑢𝑚𝑒) 
8) Label the UV sterilized uncoated 96-well microtiter plate 
9) Plate 200µL of PBS in columns 1 and 7, with 200 µL of media in the four corners  
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10) Add 200µL of each microcentrifuge tube into its corresponding plate row 
a. Shake the microcentrifuge tube before adding its contents to the plate 
11) Incubate the plate statically at the desired temperature for 24 hours 
Staining Biofilm 
12) Remove the plate from the incubator and measure OD600 values in the plate reader for growth 
comparison 
13) Invert the wells and shake the plate carefully to remove the liquid contents 
14) Wash the wells to remove excess medium and unattached cells with two boxes filled with DI 
water; blot the plate on a paper towel  
a. Repeat this step twice 
15) Add 225µL of 0.1% CV solution to each well 
16) Cover the plate with aluminum foil and incubate at room temperature for 10-15 minutes 
17) Wash the plate 3-4 times in the same manner as before, until little CV is washed out 
a. If not done gently, the biofilm will be washed away as well 
18) Place the plate upside down, tilted, and covered with aluminum foil to dry for 24 hours 
Reading the Biofilm Plate 
19) Add 225µL of 30% acetic acid solution to each well to solubilize the CV for transfer 
20) Incubate the plate at room temperature for 15 minutes 
21) Transfer the 225µL of solubilized CV to a new plate 
22) Read the plate at 590nm using the microtiter plate reader 
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7.4 Antibiotic Resistance 
7.4.1 Antibiotic Resistance Assay Materials 
Polymixin B is used as the antibiotic in this assay as it is highly effective against Gram-negative 
bacteria. This is added in two-fold increasing concentrations, as seen in step 9 below. Clear, 
polystyrene 96-well microtiter plates are used similarly to the biofilm formation protocol. 
7.4.2 Antibiotic Resistance Protocol 
1) Create 2 overnight cultures to shake at 250rpm at the desired temperature  
a. Create 1 tube of media only to serve as a control for contamination 
2) After 16-20 hours, remove the overnight cultures and pour the overnights into a 15mL 
conical, place in centrifuge, balance, and spin for 10 minutes at 4500rpm 
a. While centrifuging, create five 2mL test tubes labeled ‘-’, ‘18:2’, ‘20:4’, ‘20:5’, and 
‘22:6’ 
3) Once complete, pour off the supernatant and refill the tubes with 1 mL of media, carefully as 
to not disrupt the pellet, and spin for 10 minutes at 4500 rpm  
a. Replace these in the centrifuge with the pellet facing upward 
b. Add 300mM of each UFA to the corresponding microcentrifuge tube 
FATTY ACID VOLUME (µL) 
18:2 0.248 
20:4 0.843 
20:5 0.843 
22:6 0.909 
 
4) Once complete, pour off supernatant and re-suspend in 1 mL media 
a. This is done by breaking up the pellet with the media and pipette 
5) Measure the OD600 of the prepared inoculum 
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6) Calculate the volume of culture required to start the microcentrifuge tubes at an OD600 of 0.1, 
according to the equation below 
(𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑣𝑜𝑙𝑢𝑚𝑒)(𝜇𝐿) = 	 (𝑑𝑒𝑠𝑖𝑟𝑒𝑑	𝑂𝐷)(𝑡𝑜𝑡𝑎𝑙	𝑣𝑜𝑙𝑢𝑚𝑒)(𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑂𝐷) ∗ 1000 
7) Put a total volume of 6mL in each microcentrifuge tube, culture added last, calculating the 
amount of media to be added as follows: 𝑀𝑒𝑑𝑖𝑎	(𝜇𝐿) = 6000 − (𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑣𝑜𝑙𝑢𝑚𝑒) − (𝐹𝐴	𝑣𝑜𝑙𝑢𝑚𝑒) 
8) Place the 5 test tubes in the incubator shaking at 250rpm at experimental temperature until 
the OD600 has reached ~0.6 (approx. 2 hours) 
9) Create the PMB dilutions in 1.5mL microcentrifuge tubes as follows: 
NUMBER DILUTION 
VOLUME OF PMB 
STOCK (µL) 
VOLUME OF 
MEDIA (µL) 
1 0 0 1000 
2 40 9 991 
3 80 18 982 
4 160 36 964 
5 320 71 929 
6 640 142 858 
7 1280 284 716 
8 2560 569 431 
 
10) Label the UV sterilized uncoated 96-well microtiter plate 
11) Add 30µL of each PMB dilution to the corresponding wells 
a. Do this near the end of the growing period 
12) Pour the 5 test tubes into 5 labeled 15 mL conicals, balance the centrifuge, and centrifuge for 
10 minutes at 4500 rpm 
a. Label five 15mL conicals ‘-’, ‘18:2’, ’20:4’, ’20:5’, ’22:6’ 
13) Once done, pour off the supernatant and fill the tubes with 1 mL media and spin for 10 
minutes at 4500rpm 
a. Add 353mM of each UFA to the corresponding microcentrifuge tube 
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FATTY ACID VOLUME (µL) 
18:2 0.648 
20:4 2.205 
20:5 2.205 
22:6 2.377 
 
14) Once done spinning, pour off supernatant and resuspend in 1mL of media 
15) Take OD600 of the cultures 
16) Add the amount of culture needed to bring the inoculum to an OD600 of 0.117 according to 
the equation in step 6 
17) Bring the total volume to 4mL by adding media according to the below equation 𝑀𝑒𝑑𝑖𝑎	(𝜇𝐿) = 4000 − (𝑐𝑢𝑙𝑡𝑢𝑟𝑒	𝑣𝑜𝑙𝑢𝑚𝑒) − (𝐹𝐴	𝑣𝑜𝑙𝑢𝑚𝑒) − (30	𝜇𝐿	𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛) 
18) Add 170µL of each conical to the corresponding rows 
19) Place the plate in the incubator, taped down and on top of a rack, shaking at 250rpm 
20) Remove the plate from the shaking incubator after 24 hours and use the microtiter plate 
reader to read the plate at 600nm
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